{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,22]],"date-time":"2026-09-22T10:48:09Z","timestamp":1790074089776,"version":"4.0.1"},"reference-count":27,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2006,6,1]],"date-time":"2006-06-01T00:00:00Z","timestamp":1149120000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2015,12,2]],"date-time":"2015-12-02T00:00:00Z","timestamp":1449014400000},"content-version":"vor","delay-in-days":3471,"URL":"https:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Journal of Investigative Dermatology"],"published-print":{"date-parts":[[2006,6]]},"DOI":"10.1038\/sj.jid.5700264","type":"journal-article","created":{"date-parts":[[2006,3,23]],"date-time":"2006-03-23T11:36:58Z","timestamp":1143113818000},"page":"1251-1255","source":"Crossref","is-referenced-by-count":134,"title":["Imiquimod for Actinic Keratosis: Systematic Review and Meta-Analysis"],"prefix":"10.1016","volume":"126","author":[{"given":"Gina","family":"Hadley","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sheena","family":"Derry","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robert A.","family":"Moore","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1038\/sj.jid.5700264_bb0010","doi-asserted-by":"crossref","first-page":"250","DOI":"10.1046\/j.1440-0960.2003.00003.x","article-title":"Short-course therapy with imiquimod 5% cream for solar keratoses: A randomized control trial","volume":"44","author":"Chen","year":"2003","journal-title":"Aus J Dermatol"},{"key":"10.1038\/sj.jid.5700264_bb0015","doi-asserted-by":"crossref","first-page":"452","DOI":"10.1136\/bmj.310.6977.452","article-title":"The number needed to treat: a clinically useful measure of treatment effect","volume":"310","author":"Cook","year":"1995","journal-title":"BMJ"},{"key":"10.1038\/sj.jid.5700264_bb0020","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1016\/S0304-3959(99)00302-4","article-title":"An evaluation of homogeneity tests in meta-analyses in pain using simulations of individual patient data","volume":"85","author":"Gavaghan","year":"2000","journal-title":"Pain"},{"key":"10.1038\/sj.jid.5700264_bb0025","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1007\/s00403-004-0465-4","article-title":"Pharmacokinetics and safety of imiquimod 5% cream in the treatment of actinic keratoses of the face, scalp, or hands and arms","volume":"296","author":"Harrison","year":"2004","journal-title":"Arch Dermatol Res"},{"key":"10.1038\/sj.jid.5700264_bb0030","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/0197-2456(95)00134-4","article-title":"Assessing the quality of reports of randomized clinical trials: is blinding necessary?","volume":"17","author":"Jadad","year":"1996","journal-title":"Control Clin Trials"},{"issue":"Suppl 3","key":"10.1038\/sj.jid.5700264_bb0035","first-page":"13","article-title":"Current and novel treatment options for actinic keratosis","volume":"8","author":"Jorizzo","year":"2005","journal-title":"J Cutan Med Surg"},{"key":"10.1038\/sj.jid.5700264_bb0040","doi-asserted-by":"crossref","first-page":"467","DOI":"10.1001\/archderm.141.4.467","article-title":"Dosing with 5% imiquimod cream 3 times per week for the treatment of actinic keratosis: results of two phase 3, randomized, double-blind, parallel-group, vehicle-controlled trials","volume":"141","author":"Korman","year":"2005","journal-title":"Arch Dermatol"},{"key":"10.1038\/sj.jid.5700264_bb0045","doi-asserted-by":"crossref","first-page":"224","DOI":"10.7326\/0003-4819-107-2-224","article-title":"Meta-analysis in clinical research","volume":"107","author":"L'Abbe","year":"1987","journal-title":"Ann Intern Med"},{"key":"10.1038\/sj.jid.5700264_bb0050","doi-asserted-by":"crossref","first-page":"714","DOI":"10.1016\/j.jaad.2003.12.010","article-title":"Imiquimod 5% cream for the treatment of actinic keratosis: results from two phase III, randomized, double-blind, parallel group, vehicle-controlled trials","volume":"50","author":"Lebwohl","year":"2004","journal-title":"J Am Acad Dermatol"},{"key":"10.1038\/sj.jid.5700264_bb0055","doi-asserted-by":"crossref","first-page":"659","DOI":"10.1097\/00042728-200506000-00008","article-title":"Long-term clinical outcomes following treatment of actinic keratosis with imiquimod 5% cream","volume":"31","author":"Lee","year":"2005","journal-title":"Dermatol Surg"},{"key":"10.1038\/sj.jid.5700264_bb0060","doi-asserted-by":"crossref","first-page":"395","DOI":"10.2165\/00128071-200405060-00004","article-title":"Optimum treatment strategies for actinic keratosis (intraepidermal squamous cell carcinoma)","volume":"5","author":"Lober","year":"2004","journal-title":"Am J Clin Dermatol"},{"key":"10.1038\/sj.jid.5700264_bb0065","doi-asserted-by":"crossref","first-page":"1150","DOI":"10.1111\/j.1365-2133.2004.06236.x","article-title":"Gene expression in actinic keratoses: pharmacological modulation by imiquimod","volume":"151","author":"Lysa","year":"2004","journal-title":"Br J Dermatol"},{"key":"10.1038\/sj.jid.5700264_bb0070","doi-asserted-by":"crossref","first-page":"1154","DOI":"10.1046\/j.1365-2133.2000.03541.x","article-title":"Prevalence of solar damage and actinic keratosis in a Merseyside population","volume":"142","author":"Memon","year":"2000","journal-title":"Br J Dermatol"},{"key":"10.1038\/sj.jid.5700264_bb0075","doi-asserted-by":"crossref","first-page":"1896","DOI":"10.1016\/S0140-6736(99)04149-5","article-title":"Improving the quality of reports of meta-analyses of randomized controlled trials: the QUOROM statement. Quality of Reporting of Meta-analyses","volume":"354","author":"Moher","year":"1999","journal-title":"Lancet"},{"key":"10.1038\/sj.jid.5700264_bb0080","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1186\/1471-2334-1-3","article-title":"Imiquimod for the treatment of genital warts: a quantitative systematic review","volume":"1","author":"Moore","year":"2001","journal-title":"BMC Infect Dis"},{"key":"10.1038\/sj.jid.5700264_bb0085","series-title":"Statistics with Confidence \u2013 Confidence Intervals and Statistical Guidelines","first-page":"50","article-title":"Calculating confidence intervals for relative risk, odds ratios and standardised ratios and rates","author":"Morris","year":"1995"},{"key":"10.1038\/sj.jid.5700264_bb0090","first-page":"1","article-title":"Imiquimod 5% cream for actinic keratosis","volume":"61","author":"Perras","year":"2004","journal-title":"Issues Emerg Health Technol"},{"key":"10.1038\/sj.jid.5700264_bb0095","doi-asserted-by":"crossref","first-page":"553","DOI":"10.1067\/mjd.2002.123492","article-title":"Clinical effect of imiquimod 5% cream in the treatment of actinic keratosis","volume":"47","author":"Persaud","year":"2002","journal-title":"J Am Acad Dermatol"},{"key":"10.1038\/sj.jid.5700264_bb0100","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1007\/s00403-005-0601-9","article-title":"Three percent diclofenac in 2.5% hyaluron gel in the treatment of actinic keratosis: a meta-analysis of the recent studies","volume":"297","author":"Pirad","year":"2005","journal-title":"Arch Dermatol Res"},{"key":"10.1038\/sj.jid.5700264_bb0105","doi-asserted-by":"crossref","first-page":"571","DOI":"10.1067\/mjd.2002.126257","article-title":"Cycle therapy of actinic keratoses of the face and scalp with 5% topical imiquimod cream: An open-label trial","volume":"47","author":"Salasche","year":"2002","journal-title":"J Am Acad Dermatol"},{"issue":"Suppl 66","key":"10.1038\/sj.jid.5700264_bb0110","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1046\/j.0366-077X.2003.05628.x","article-title":"Imiquimod: modes of action","volume":"149","author":"Sauder","year":"2003","journal-title":"Br J Dermatol"},{"key":"10.1038\/sj.jid.5700264_bb0115","doi-asserted-by":"crossref","first-page":"1119","DOI":"10.1016\/S0895-4356(00)00242-0","article-title":"Publication and related bias in meta-analysis: power of statistical tests and prevalence in the literature","volume":"53","author":"Sterne","year":"2000","journal-title":"J Clin Epidemiol"},{"key":"10.1038\/sj.jid.5700264_bb0120","doi-asserted-by":"crossref","first-page":"1542","DOI":"10.1001\/archderm.140.12.1542-a","article-title":"Low incidence of new actinic keratoses after topical 5% imiquimod cream treatment: a long-term follow-up study","volume":"140","author":"Stockfleth","year":"2004","journal-title":"Arch Dermatol"},{"key":"10.1038\/sj.jid.5700264_bb0125","doi-asserted-by":"crossref","first-page":"547","DOI":"10.1016\/j.jaad.2004.02.022","article-title":"Imiquimod 5% cream for the treatment of actinic keratosis: results from a phase III, randomized, double-blind, vehicle controlled, clinical trial with histology","volume":"51","author":"Szeimies","year":"2004","journal-title":"J Am Acad Dermatol"},{"key":"10.1038\/sj.jid.5700264_bb0130","doi-asserted-by":"crossref","first-page":"894","DOI":"10.1016\/j.jclinepi.2005.01.006","article-title":"In an empirical evaluation of the funnel plot, researchers could not visually identify publication bias","volume":"58","author":"Terrin","year":"2005","journal-title":"J Clin Epidemiol"},{"key":"10.1038\/sj.jid.5700264_bb0135","doi-asserted-by":"crossref","first-page":"507","DOI":"10.1001\/archderm.141.4.507","article-title":"Clinical recognition of actinic keratoses in a high-risk population. How good are we?","volume":"141","author":"Venna","year":"2005","journal-title":"Arch Dermatol"},{"key":"10.1038\/sj.jid.5700264_bb0140","first-page":"1055","article-title":"Reliability of counting actinic keratoses before and after brief consensus discussion: the VA topical tretinoin chemoprevention (VATTC) trial","volume":"137","author":"Weinstock","year":"2001","journal-title":"Arch Dermatol"}],"container-title":["Journal of Investigative Dermatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022202X1532916X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022202X1532916X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,4,17]],"date-time":"2019-04-17T10:04:02Z","timestamp":1555495442000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0022202X1532916X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2006,6]]},"references-count":27,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2006,6]]}},"alternative-id":["S0022202X1532916X"],"URL":"https:\/\/doi.org\/10.1038\/sj.jid.5700264","relation":{},"ISSN":["0022-202X"],"issn-type":[{"value":"0022-202X","type":"print"}],"subject":[],"published":{"date-parts":[[2006,6]]}}}